Synthetic mucins shed light on cancer biology and tumor formation

During cold and flu season, excess mucus is a common, unpleasant symptom of illness, but the slippery substance is essential to human health.

Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City | Psychedelic Invest

– Company speakers include Doug Drysdale, Chief Executive Officer; and Amir Inamdar, MBBS, DNB (Psych), MFPM, Chief Medical Officer – – Featured key opinion leaders

November 20, 2023

Exclusive: Providence just launched a startup for one of hospitals’ biggest problems — maintaining patient relationships

Providence, a massive health system based in the Seattle area with 51 hospitals, is launching a new company called Praia Health. The startup wants to

October 3, 2023

Early exposure to air pollution associated with lower economic earnings in adulthood

Higher exposure to fine particulate air pollution (PM2.5) during infancy was associated with lower economic earnings in adulthood in a new study from Harvard T.H.

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.